Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease
- PMID: 30543657
- PMCID: PMC6292612
- DOI: 10.1371/journal.pone.0207878
Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease
Abstract
Objective: To evaluate the association of rainy season with overall dengue disease incidence and with the efficacy of the Sanofi Pasteur recombinant, live, attenuated, tetravalent vaccine (CYD-TDV) in two randomized, controlled multicenter phase III clinical trials in Asia and Latin America.
Methods: Rainy seasons were defined for each study site using climatological information from the World Meteorological Organization. The dengue attack rate in the placebo group for each study month was calculated as the number of symptomatic, virologically-confirmed dengue events in a given month divided by the number of participants at risk in the same month. Time-dependent Cox proportional hazard models were used to test whether rainy season was associated with dengue disease and whether it modified vaccine efficacy in each of the two trials and in both of the trials combined.
Findings: Rainy season, country, and age were all significantly associated with dengue disease in both studies. Vaccine efficacy did not change during the rainy season in any of the analyses.
Conclusions: Although dengue transmission and exposure are expected to increase during the rainy season, our results indicate that CYD-TDV vaccine efficacy remains constant throughout the year in endemic regions.
Conflict of interest statement
I have read the journal’s policy and the authors of this manuscript have the following competing interests; ZM, MEH and PG were funded by contracts from Sanofi Pasteur. EL, RLO, MC, CF and LC are employees of Sanofi Pasteur. GC was employed as a Principal Investigator Coordinator by Fundacion Santa Fe de Bogotá who were contracted by Sanofi Pasteur to conduct the CYD15 study at five of the nine sites in Colombia. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Figures



Similar articles
-
Efficacy of a tetravalent dengue vaccine in children in Latin America.N Engl J Med. 2015 Jan 8;372(2):113-23. doi: 10.1056/NEJMoa1411037. Epub 2014 Nov 3. N Engl J Med. 2015. PMID: 25365753 Clinical Trial.
-
Estimating the public health importance of the CYD-tetravalent dengue vaccine: Vaccine preventable disease incidence and numbers needed to vaccinate.Vaccine. 2016 Apr 29;34(20):2397-401. doi: 10.1016/j.vaccine.2016.03.017. Epub 2016 Apr 5. Vaccine. 2016. PMID: 27055020
-
Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America.J Infect Dis. 2016 Oct 1;214(7):994-1000. doi: 10.1093/infdis/jiw297. Epub 2016 Jul 14. J Infect Dis. 2016. PMID: 27418050 Free PMC article.
-
Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease.Drugs. 2016 Sep;76(13):1301-1312. doi: 10.1007/s40265-016-0626-8. Drugs. 2016. PMID: 27506852 Review.
-
Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward.Vaccine. 2015 Dec 10;33(50):7100-11. doi: 10.1016/j.vaccine.2015.09.108. Epub 2015 Oct 20. Vaccine. 2015. PMID: 26475445 Review.
Cited by
-
Analysis of effects of meteorological variables on dengue incidence in Bangladesh using VAR and Granger causality approach.Front Public Health. 2024 Nov 28;12:1488742. doi: 10.3389/fpubh.2024.1488742. eCollection 2024. Front Public Health. 2024. PMID: 39668959 Free PMC article.
-
Prediction of dengue annual incidence using seasonal climate variability in Bangladesh between 2000 and 2018.PLOS Glob Public Health. 2022 May 9;2(5):e0000047. doi: 10.1371/journal.pgph.0000047. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962108 Free PMC article.
-
Factors associated with severe dengue in Savannakhet Province, Lao People's Democratic Republic.Nagoya J Med Sci. 2021 Nov;83(4):749-763. doi: 10.18999/nagjms.83.4.749. Nagoya J Med Sci. 2021. PMID: 34916719 Free PMC article.
References
-
- WHO. Dengue and severe dengue. http://www.who.int/mediacentre/factsheets/fs117/en/ [updated May 2015].
-
- Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012;6(8):e1760 10.1371/journal.pntd.0001760 - DOI - PMC - PubMed
-
- Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504–7. 10.1038/nature12060 - DOI - PMC - PubMed
-
- Guzman MG, Kouri G, Bravo J, Soler M, Martinez E. Sequential infection as risk factor for dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) during the 1981 dengue hemorrhagic Cuban epidemic. Mem Inst Oswaldo Cruz. 1991;86(3):367 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical